JPH05123190A - Reagent for detecting labeled peroxidase for immunoblotting analysis - Google Patents

Reagent for detecting labeled peroxidase for immunoblotting analysis

Info

Publication number
JPH05123190A
JPH05123190A JP31015491A JP31015491A JPH05123190A JP H05123190 A JPH05123190 A JP H05123190A JP 31015491 A JP31015491 A JP 31015491A JP 31015491 A JP31015491 A JP 31015491A JP H05123190 A JPH05123190 A JP H05123190A
Authority
JP
Japan
Prior art keywords
reagent
solution
concentration
membrane
hydrogen peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP31015491A
Other languages
Japanese (ja)
Other versions
JPH0763396B2 (en
Inventor
Toshio Imai
利夫 今井
Shigeo Ochi
繁夫 越智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruzen Petrochemical Co Ltd
Original Assignee
Maruzen Petrochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruzen Petrochemical Co Ltd filed Critical Maruzen Petrochemical Co Ltd
Priority to JP31015491A priority Critical patent/JPH0763396B2/en
Publication of JPH05123190A publication Critical patent/JPH05123190A/en
Publication of JPH0763396B2 publication Critical patent/JPH0763396B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain the subject reagent having excellent color-developing stability and extremely high sensitivity and free from carcinogenecity by dissolving methyl-benzothiazolinone hydrazone salt, a specific phenolic compound and H2O2 in a buffering solution and adjusting the pH of the mixture. CONSTITUTION:The objective reagent is produced by dissolving (A) 3-methyl-2- benzothiazolinone hydrazone salt, (B) a phenolic compound of formula (B is CH3, H, etc.; A is NH2, NHCH3, etc.; X is HCl, HCOOH, etc.; (n) is 0, 1/2 or 1) (preferably p-dimethylaminophenol, etc.) and (C) hydrogen peroxide in a buffering solution (preferably a phosphate buffering solution composed of a monobasic phosphate) and adjusting the pH of the solution to 7.1-9. The amounts of the components A and B are preferably 1-2mM and 5-20mM based on 1L of the solution, respectively. The concentration of the component C is preferably 0.2-0.4mM.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、タンパク質の有用な分
析法として利用されているイムノブロット法において、
標識酵素として汎用されているペルオキシダーゼ(以下
PODと略称する)の検出用試薬に関する。
TECHNICAL FIELD The present invention relates to an immunoblot method used as a useful analytical method for proteins,
The present invention relates to a reagent for detecting peroxidase (hereinafter abbreviated as POD) that is widely used as a labeling enzyme.

【0002】[0002]

【従来の技術】タンパク質を各種ゲル電気泳動法で分離
した後、これをニトロセルロース等の膜に移し取り、膜
上で抗原抗体反応を行なうことにより、特定の蛋白質
(抗原)を検出・同定する方法をイムノブロット分析法
と呼んでいる。膜上の蛋白を検出するには、放射性同位
元素で標識した抗体を用いるオートラジオグラフィを行
なう方法と、酵素を結合した抗体を用い化学的に検出す
る方法とがあるが、取扱いの容易な後者の方法が多く採
用されている。従来、イムノブロット法における抗体の
標識酵素として用いられてきたPODの検出用試薬とし
て、ジアミノベンチジン(以下DABと略称する)が、
検出感度の高いことから古くから用いられてきた。しか
しその発ガン性が指摘されて以来、DAB以外の各種試
薬が検討され、発ガン性のない4−クロロ−1−ナフト
ールやニトロテトラゾリウム塩等が開発されているが、
それらの試薬は必ずしも検出感度が十分ではなかった。
この観点から開発されたPOD検出試薬組成物として、
特公昭61−75には、3−メチル−2−ベンゾチアゾ
リノンヒドラゾン塩酸塩とフェノール化合物をpH5〜
7の条件下で用いることが開示されている。この検出試
薬は発ガン性がなく感度の点でも優れたものであった。
BACKGROUND ART Proteins are separated by various gel electrophoresis methods, transferred to a membrane such as nitrocellulose, and an antigen-antibody reaction is carried out on the membrane to detect and identify a specific protein (antigen). The method is called immunoblot analysis. To detect proteins on the membrane, there are a method of performing autoradiography using an antibody labeled with a radioisotope and a method of chemically detecting using an antibody to which an enzyme is bound, but the latter is easy to handle. This method is often adopted. Conventionally, diaminobenzidine (hereinafter abbreviated as DAB) has been used as a POD detection reagent that has been used as a labeling enzyme for antibodies in immunoblotting.
It has been used for a long time because of its high detection sensitivity. However, since its carcinogenicity was pointed out, various reagents other than DAB have been investigated and 4-chloro-1-naphthol, nitrotetrazolium salt, etc., which have no carcinogenicity have been developed,
The detection sensitivity of these reagents was not always sufficient.
As a POD detection reagent composition developed from this viewpoint,
In JP-B-61-75, 3-methyl-2-benzothiazolinone hydrazone hydrochloride and a phenol compound are added at a pH of 5 to 5.
The use under the conditions of 7 is disclosed. This detection reagent was not carcinogenic and was excellent in terms of sensitivity.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、この検
出試薬は組織標本のPODを検出することを意図したも
のであったため、イムノブロット法にはそのまま適用で
きなかった。すなわち、イムノブロット法の場合、前記
化合物をpH5〜7の条件を用いて使用すると、前記化
合物の溶解性が必ずしも十分でないため、発色反応の効
率が低くなりタンパク質検出能が低下するという問題が
明らかになった。また発色安定性も劣るという問題も明
らかになった。
However, since this detection reagent was intended to detect POD of a tissue specimen, it could not be directly applied to the immunoblotting method. That is, in the case of the immunoblotting method, when the compound is used under the condition of pH 5 to 7, the solubility of the compound is not always sufficient, so that the efficiency of the color reaction is lowered and the protein detectability is lowered. Became. Further, it became clear that the color development stability was also poor.

【0004】本発明はこのような事情に鑑みなされたも
のであり、イムノブロット法における高感度のPOD検
出を可能にしたものである。すなわち、本発明は発ガン
性が無く、発色安定性に優れ、かつ公知の試薬に比べは
るかに感度の優れたイムノブロット法における標識PO
Dの検出試薬を提供することを目的とする。
The present invention has been made in view of the above circumstances, and enables highly sensitive POD detection in immunoblotting. That is, the present invention has no carcinogenicity, excellent coloration stability, and much higher sensitivity than known reagents in labeled blotting in immunoblotting.
It is intended to provide a D detection reagent.

【0005】[0005]

【問題を解決するための手段および作用効果】本発明
は、3−メチル−2−ベンゾチアゾリノンヒドラゾン塩
(以下MBTHと略称する)と、下記の一般式で示され
るフェノール化合物と、過酸化水素とを緩衝液中に溶解
せしめ、pH7.1〜8.0に調整してなるイムノブロ
ット分析用標識ペルオキシダーゼの検出試薬である。
MEANS FOR SOLVING PROBLEMS AND EFFECTS OF THE INVENTION The present invention provides a 3-methyl-2-benzothiazolinone hydrazone salt (hereinafter abbreviated as MBTH), a phenol compound represented by the following general formula, and a peroxide. It is a reagent for detecting labeled peroxidase for immunoblot analysis, which is prepared by dissolving hydrogen and a buffer solution and adjusting the pH to 7.1 to 8.0.

【0006】[0006]

【化2】 [Chemical 2]

【0007】ここで、MBTHは下記構造を示す化合物
である。
MBTH is a compound having the following structure.

【0008】[0008]

【化3】 [Chemical 3]

【0009】上記構造式ではMBTHの塩酸塩を示した
が、本発明の検出試薬におけるMBTHは他の水溶性塩
を用いてもよい。
Although the above structural formula shows the hydrochloride salt of MBTH, other water-soluble salts may be used for MBTH in the detection reagent of the present invention.

【0010】本発明の検出試薬に用いるフェノール化合
物は上記一般式に示されるものであり、これらの中、p
−ジメチルアミノフェノール、o−アミノフェノール、
m−アミノフェノール、p−メチルアミノフェノール硫
酸塩、2−クロル−6−メチルフェノール、4−クロル
−3−メチルフェノール、2,3−ジクロルフェノー
ル、2,6−ジクロルフェノール、o−クロルフェノー
ル、o−メトキシフェノール、p−メトキシフェノール
などが特に有効である。
The phenol compound used in the detection reagent of the present invention is represented by the above general formula.
-Dimethylaminophenol, o-aminophenol,
m-aminophenol, p-methylaminophenol sulfate, 2-chloro-6-methylphenol, 4-chloro-3-methylphenol, 2,3-dichlorophenol, 2,6-dichlorophenol, o-chloro Phenol, o-methoxyphenol, p-methoxyphenol and the like are particularly effective.

【0011】両者の割合はMBTHが0.5〜5ミリモ
ル、フェノール化合物3〜25ミリモル(いずれも溶液
1L当りの量)の範囲内である。この範囲よりいずれか
が少ないとタンパク質の発色に問題があり、いずれかが
多い場合には溶液が懸濁状態となり好ましくない。本範
囲の内、MBTHは1〜2mM、フェノール化合物は5
〜20mMの範囲が特に好ましいものである。
The ratio of the two is within the range of 0.5 to 5 millimoles of MBTH and 3 to 25 millimoles of the phenol compound (both are amounts per 1 L of the solution). If there is less than this range, there is a problem in the color development of the protein, and if there is more than one, the solution is in a suspended state, which is not preferable. Within this range, MBTH is 1-2 mM and phenolic compounds are 5
The range of up to 20 mM is particularly preferred.

【0012】過酸化水素の濃度は、発色の程度に影響を
及ぼす重要な因子である。通常過酸化水素の濃度は0.
1〜0.6mMで、この範囲外であるとタンパク質の発
色が低下し好ましくない。特に過酸化水素濃度は0.2
〜0.4mMが好ましい。
The concentration of hydrogen peroxide is an important factor affecting the degree of color development. Usually, the concentration of hydrogen peroxide is 0.
If the amount is in the range of 1 to 0.6 mM, it is not preferable if the amount is out of this range, the color development of the protein decreases. Especially hydrogen peroxide concentration is 0.2
~ 0.4 mM is preferred.

【0013】MBTH及びフェノール化合物を溶解せし
める緩衝液としては、リン酸塩緩衝液、マレイン酸塩緩
衝液、カコジル酸ナトリウム緩衝液等が用いられ、これ
らの中、第1リン酸塩よりなるリン酸塩緩衝液が好まし
い。その溶液のpHは7.1〜9.0に調整することが
肝要である。pHが7.1以下であると、フェノール化
合物の溶解度が低下するため発色反応効率が低く、検出
するタンパク質の発色が低下し、感度の低下を招く。ま
た発色安定性も低下するので好ましくない。pHが9.
0以上になると発色反応が阻害され、好ましくない。特
に好ましいpHは7.2〜7.6の範囲である。緩衝液
中の塩濃度は、できるだけ小さいことが好ましく、0.
05〜0.1Mの範囲が一般的に好ましい。
As a buffer solution for dissolving MBTH and a phenol compound, a phosphate buffer solution, a maleate buffer solution, a sodium cacodylate buffer solution, etc. are used. Of these, the phosphate consisting of the primary phosphate is used. Salt buffer is preferred. It is important to adjust the pH of the solution to 7.1 to 9.0. When the pH is 7.1 or less, the solubility of the phenol compound is lowered, the efficiency of the color reaction is low, the color of the protein to be detected is low, and the sensitivity is lowered. Further, the coloration stability is also lowered, which is not preferable. pH is 9.
When it is 0 or more, the coloring reaction is hindered, which is not preferable. A particularly preferable pH is in the range of 7.2 to 7.6. The salt concentration in the buffer is preferably as low as possible, and
A range of 05 to 0.1M is generally preferred.

【0014】本発明の検出試薬を用いるにあたって、検
出試薬中の各化合物、緩衝剤はいずれも所定濃度となる
ように混合して保存してもよいが、MBTH、フェノー
ル化合物および過酸化水素をそれぞれ所定倍濃度になる
ように緩衝液に別々に溶解して保存し、使用時に各溶液
を混合して所定濃度、所定pHとなるようにして検出
(発色)反応に用いるようにしてもよい。なお本発明の
検出試薬は、例えばニトロセルロース膜、PVDF(Po
lyvinylidene difluoride )膜、ナイロン膜等の各種の
ブロット転写膜に使用することができる。
When the detection reagent of the present invention is used, each compound and buffer in the detection reagent may be mixed and stored so as to have a predetermined concentration, but MBTH, a phenol compound and hydrogen peroxide are respectively stored. You may make it melt | dissolve in a buffer solution separately so that it may become a predetermined | prescribed density | concentration, preserve | save, and mix each solution at the time of use so that it may become a predetermined concentration and predetermined pH, and it may be made to use for a detection (color development) reaction. The detection reagent of the present invention is, for example, a nitrocellulose membrane, PVDF (Po
It can be used for various blot transfer films such as lyvinylidene difluoride) film and nylon film.

【0015】本発明は、イムノブロット法における標識
酵素であるPODの検出試薬として用いられていた発ガ
ン物質DABの代替にかかる試薬を提供するのみなら
ず、DABを始めとする従来公知の検出試薬よりもはる
かに高感度な試薬を提供するものであり、従来のイムノ
ブロット法によるタンパク質検出では検出不可能であっ
た極微量のタンパク質の検出が可能となり、その効果は
極めて大である。本発明に係る検出試薬は、αフェトプ
ロテインを始めとする腫瘍マーカー等のイムノブロット
による検出・同定に特に有用である。
The present invention not only provides a reagent for substituting the carcinogen DAB used as a detection reagent for POD which is a labeling enzyme in immunoblotting, but also a conventionally known detection reagent such as DAB. It provides a reagent with a much higher sensitivity than the conventional one, and enables detection of an extremely small amount of protein which cannot be detected by conventional protein detection by immunoblotting, and the effect is extremely large. The detection reagent according to the present invention is particularly useful for detecting / identifying tumor markers such as α-fetoprotein by immunoblotting.

【0016】以下に実施例を挙げて本発明をさらに詳細
に説明するが、本発明はこの実施例に限定されるもので
はない。なお、下記実施例、比較例は、いずれも電気泳
動後に膜に転写(ブロット)した後の染色工程のみを想
定したものであり、イムノブロット法の前段階、すなわ
ち電気泳動及びブロッティングの操作は省略した。
Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. It should be noted that the following Examples and Comparative Examples all assume only the staining step after transfer (blotting) to the membrane after electrophoresis, and the steps before the immunoblotting, that is, the operations of electrophoresis and blotting are omitted. did.

【0017】[0017]

【実施例】精製ヒトαフェトプロテイン(αFP、IB
L社製)の12.0,6.0, 3.0, 1.5,0.7, 0.35, 0.17及び0.
08ng/ml のリン酸緩衝液(pH7.1)のそれぞれ1μL を、
PVDF(Polyvinylidene difluoride )膜に点着し
た。つぎに、αFPを添加したPVDF膜を4%BSA
(ウシ血清アルブミン)−PBS(燐酸緩衝生理食塩
水)溶液中に浸し、37℃、60分浸盪し、膜のタンパク未
吸着分をすべてBSAでブロックした。4%BSA−P
BS溶液を除去後、PBS溶液を加え、同様に5分間浸
盪した。さらに新しいPBS溶液に代えて3回この操作
を繰り返した。洗浄終了後、PVDF膜を検出反応用ト
レイに移し、膜上に1次抗体溶液(抗ヒトαFPモノク
ローナル抗体5mgを500 μL の蒸留水に溶解後、抗体希
釈溶液(燐酸緩衝液)で20倍に希釈したもの)5mLを
注いだ。37℃で60分間反応させた後、0.05%Tween 20含
有PBS溶液でPVDF膜を5分間ずつ3回洗浄後、P
VDF膜にPOD標識2次抗体(抗ヒトIgG(家兎)
POD標識IgG(DAKO製)溶液5μL を抗体希釈
溶液5mLで希釈する。)5mLを注いだ。37℃で45分間反
応させた後、0.05%Tween 20含有PBS溶液でPVDF
膜を5分間ずつ5回洗浄した。
Example Purified human α-fetoprotein (αFP, IB
L company) 12.0, 6.0, 3.0, 1.5, 0.7, 0.35, 0.17 and 0.
1 μL each of 08 ng / ml phosphate buffer (pH 7.1)
It was spotted on a PVDF (Polyvinylidene difluoride) film. Next, the PVDF membrane with αFP added was mixed with 4% BSA.
The membrane was immersed in a (bovine serum albumin) -PBS (phosphate buffered saline) solution and shaken at 37 ° C. for 60 minutes to block all unadsorbed protein on the membrane with BSA. 4% BSA-P
After removing the BS solution, the PBS solution was added, and the mixture was similarly agitated for 5 minutes. Further, this operation was repeated 3 times in place of a new PBS solution. After washing, transfer the PVDF membrane to the detection reaction tray, dissolve the primary antibody solution (5 mg of anti-human αFP monoclonal antibody in 500 μL of distilled water) on the membrane, and then 20 times with the antibody diluted solution (phosphate buffer solution). Diluted) 5 mL was poured. After reacting at 37 ° C for 60 minutes, the PVDF membrane was washed 3 times for 5 minutes each with a PBS solution containing 0.05% Tween 20, and then P
POD-labeled secondary antibody on VDF membrane (anti-human IgG (rabbit)
Dilute 5 μL of POD-labeled IgG (manufactured by DAKO) solution with 5 mL of antibody dilution solution. ) 5 mL was poured. After reacting at 37 ℃ for 45 minutes, add 0.05% Tween 20 in PBS to PVDF
The membrane was washed 5 times for 5 minutes each.

【0018】6.3 mMのMBTH(0.1Mリン酸緩衝液:pH
7.1 )を5mL、25.2mMの2,6-ジクロロフェノールを(0.
1Mリン酸緩衝液:pH7.1 )を25mL、および6.3mM の過酸
化水素(0.1Mリン酸緩衝液:pH7.1 )を1.5mL を混合し
て、検出試薬を調製した。混合後の濃度は、MBTHは
1mM、2,6-ジクロロフェノールは20mM、過酸化水素は0.
3mM である。標識POD活性を検出するために、PVD
F膜上に検出試薬を1スポットあたり検出試薬を1.5mL
程度注ぎ、室温で2〜5分間反応させた。膜を水道水で
1〜2分間流洗し反応を停止させ、乾燥後、各スポット
の発色の程度をデンシトメーター(OD555nm )で測定
した。測定結果を図1の(A)に示す。
6.3 mM MBTH (0.1 M phosphate buffer: pH
7.1) 5 mL, 25.2 mM 2,6-dichlorophenol (0.
A detection reagent was prepared by mixing 25 mL of 1 M phosphate buffer: pH 7.1 and 1.5 mL of 6.3 mM hydrogen peroxide (0.1 M phosphate buffer: pH 7.1). The concentrations after mixing were 1 mM for MBTH, 20 mM for 2,6-dichlorophenol, and 0,0 for hydrogen peroxide.
It is 3 mM. To detect labeled POD activity, PVD
1.5 mL of detection reagent per spot on F membrane
The mixture was poured to about 3 minutes and reacted at room temperature for 2 to 5 minutes. The membrane was washed with tap water for 1-2 minutes to stop the reaction, and after drying, the degree of color development of each spot was measured with a densitometer (OD 555nm ). The measurement result is shown in FIG.

【0019】[0019]

【比較例】実施例と同じαFPの24.0, 12.0, 6.0, 3.
0, 1.5, 0.7 ng/mLのリン酸緩衝液(pH7.1 )のそれぞ
れ1μL をPVDF膜に点着し、実施例と同様の方法で
1次抗体およびPOD標識2次抗体をαFPに標識した
後、0.05%DAB、0.04%過酸化水素、トリス-HCl緩衝
液(pH7.5) の検出試薬を、PVDF膜上に1スポット当
り1.5mL 程度注ぎ、室温で2〜5分間反応させた。膜を
水道水で1〜2分間流洗し反応を停止させ、乾燥後、各
スポットの発色の程度を最大吸収波長である480nm でデ
ンシトメーターにより測定した。測定結果を図1の
(B)に示す。
[Comparative Example] 24.0, 12.0, 6.0, 3.
1 μL of each of 0, 1.5 and 0.7 ng / mL phosphate buffer (pH 7.1) was spotted on the PVDF membrane, and αFP was labeled with the primary antibody and the POD-labeled secondary antibody in the same manner as in Example. Thereafter, detection reagents of 0.05% DAB, 0.04% hydrogen peroxide and Tris-HCl buffer (pH 7.5) were poured on the PVDF membrane at about 1.5 mL per spot and reacted at room temperature for 2 to 5 minutes. The membrane was washed with tap water for 1-2 minutes to stop the reaction, and after drying, the degree of color development of each spot was measured with a densitometer at 480 nm, which is the maximum absorption wavelength. The measurement result is shown in FIG.

【0020】図1の(A)(B)の結果から明らかなよ
うに、本発明の試薬では0.08ng/mLまでのαFPの検出
が可能であるのに対し、DAB法では3.0ng/mL以下では
検出限界(カットオフ値:0.01)以下で約6.0 ng/mL ま
でしか検出できず、本発明の試薬の検出感度がDABに
比べ著しく向上していた。また本発明の試薬によって発
色したスポットの退色の程度もDABのそれに比べ小さ
く、発色安定性に優れていた。
As is clear from the results of (A) and (B) in FIG. 1, the reagent of the present invention can detect αFP up to 0.08 ng / mL, whereas the DAB method does not exceed 3.0 ng / mL. With the detection limit (cutoff value: 0.01) or less, only up to about 6.0 ng / mL could be detected, and the detection sensitivity of the reagent of the present invention was remarkably improved as compared with DAB. Further, the degree of fading of spots developed by the reagent of the present invention was smaller than that of DAB, and the coloration stability was excellent.

【図面の簡単な説明】[Brief description of drawings]

【図1】実施例および比較例の各スポットの発色濃度を
示す図である。(A)は実施例を、(B)は比較例を示
す。
FIG. 1 is a diagram showing a color density of each spot of an example and a comparative example. (A) shows an example, (B) shows a comparative example.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 3−メチル−2−ベンゾチアゾリノンヒ
ドラゾン塩と、下記の一般式で示されるフェノール化合
物と、過酸化水素とを緩衝液中に溶解せしめ、pH7.
1〜9.0に調整してなるイムノブロット分析用標識ペ
ルオキシダーゼの検出試薬。 一般式 【化1】
1. A 3-methyl-2-benzothiazolinone hydrazone salt, a phenol compound represented by the following general formula, and hydrogen peroxide are dissolved in a buffer solution to give a pH of 7.
A reagent for detecting labeled peroxidase for immunoblot analysis, which is adjusted to 1 to 9.0. General formula:
【請求項2】 前記3−メチル−2−ベンゾチアゾリノ
ンヒドラゾン塩の濃度が0.5〜5mMであり、前記フ
ェノール化合物の濃度が3〜25mMであり、前記過酸
化水素の濃度が0.1〜0.6mMであることを特徴と
する請求項 1に記載の検出試薬。
2. The concentration of the 3-methyl-2-benzothiazolinone hydrazone salt is 0.5 to 5 mM, the concentration of the phenol compound is 3 to 25 mM, and the concentration of the hydrogen peroxide is 0. The detection reagent according to claim 1, which is 1 to 0.6 mM.
【請求項3】 前記緩衝液がリン酸緩衝液であることを
特徴とする請求項 1又は2に記載の検出試薬。
3. The detection reagent according to claim 1, wherein the buffer solution is a phosphate buffer solution.
JP31015491A 1991-10-30 1991-10-30 Reagent for detection of labeled peroxidase for immunoblot analysis Expired - Lifetime JPH0763396B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP31015491A JPH0763396B2 (en) 1991-10-30 1991-10-30 Reagent for detection of labeled peroxidase for immunoblot analysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31015491A JPH0763396B2 (en) 1991-10-30 1991-10-30 Reagent for detection of labeled peroxidase for immunoblot analysis

Publications (2)

Publication Number Publication Date
JPH05123190A true JPH05123190A (en) 1993-05-21
JPH0763396B2 JPH0763396B2 (en) 1995-07-12

Family

ID=18001810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31015491A Expired - Lifetime JPH0763396B2 (en) 1991-10-30 1991-10-30 Reagent for detection of labeled peroxidase for immunoblot analysis

Country Status (1)

Country Link
JP (1) JPH0763396B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102305852A (en) * 2011-05-17 2012-01-04 湖州麦迪诺华医疗科技有限公司 Coloring agent for in vitro diagnostic device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102305852A (en) * 2011-05-17 2012-01-04 湖州麦迪诺华医疗科技有限公司 Coloring agent for in vitro diagnostic device

Also Published As

Publication number Publication date
JPH0763396B2 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
JP3503890B2 (en) Improved immunohistochemical staining method and reagents therefor
US4503143A (en) Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
US20070264647A1 (en) Stabilization of H2O2 under alkaline conditions for use in luminescence, fluorescence and colorimetric assays fro enhanced detection of peroxidase type assays
EP0481020B1 (en) Silver enhanced gold-labelled immuno assay method
US4940660A (en) Color developing method in clinical examinations
US4622293A (en) Iodothyronine immunoassays employing HMS as TBP blocking agent
US5176999A (en) Buffered wash composition, insolubilizing composition, test kits and method of use
JP2000258420A (en) Stabilizing method of human-hemoglobin in solution and stabilizing solution
JP2000193668A (en) Composition for measuring trace amount of protein
JPH05123190A (en) Reagent for detecting labeled peroxidase for immunoblotting analysis
JPH0643160A (en) Reagent for treating body fluid in measurement of neopterine and method of treating body fluid
JP3711544B2 (en) Chemiluminescence measuring reagent
JP3702476B2 (en) Chemiluminescence measurement method
JP2694004B2 (en) Method for measuring fructosamine in serum or plasma
JP3702545B2 (en) Chemiluminescent reagent
JPH07121235B2 (en) Indicator and reagent kit for measuring peroxide-decomposable substances
JP2522970B2 (en) Test piece for determination of creatinine in body fluid and method for producing the same
JPH0638757B2 (en) Peroxidase or H ▲ lower 2 ▼ O ▲ lower 2 ▼ measuring method
JP2885092B2 (en) Method and reagent for measuring C-reactive protein
JPH07308200A (en) Composition for detecting and measuring activity of peroxidase-like substance and detecting and measuring oxidizing substance and measuring method therefor
JPH0880199A (en) Measurement of oxidizing substance, measurement of peroxidase-like substance, enzyme immunoassay or enzyme immunoassay dyeing and lyophilized composition to be used for these assays
JP3839133B2 (en) Stabilized chemiluminescent reagent
JP3614951B2 (en) Methods and reagents for measuring enzyme activity
JPH0599928A (en) Reagent composition for detection of copper ion in urine
JPS62218866A (en) Reagent for quantitative analysis of human c-reactive protein